Accessibility Menu
Cyanotech logo

Cyanotech(OTC) CYAN

Market Cap$3.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)-55%
5 YearN/A
1 Year+55%
1 Month-15%
$0.45
+0.00%
+0.00Today
Cyanotech last closing stock price
MetricPriceDate
Last closeUSD 0.452026-08-25
Cyanotech stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.452026-08-18
1 month-15.05%USD 0.532026-07-21
3 month-13.44%USD 0.522026-05-26
Year to date+0%USD 0.452025-12-31
1 year+55.17%USD 0.292025-08-25
Since inception-55%USD 1.001990-10-24

Cyanotech Financials at a Glance

Market Cap

$3.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$27.23M

Net Income (TTM)

-$69.00K

EPS (TTM)

-$0.01

P/E Ratio

-50.00

Dividend

$0.00

Beta (Volatility)

0.22 (Low)

Price

$0.45

Volume

19,290

Open

$0.49

Previous Close

$0.45

Daily Range

$0.45 - $0.50

52-Week Range

$0.23 - $0.57

Estimated Earnings Date

Feb 9, 2026

CYAN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cyanotech

Cyanotech Corporation, established in 1983 and headquartered in Kailua-Kona, Hawaii, specializes in the global cultivation, processing, and distribution of natural products derived from microalgae. The company is known for its key products, including BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica, which are recognized for their health benefits.

Products and Services
  • BioAstin Hawaiian Astaxanthin, a powerful dietary antioxidant
  • Hawaiian Spirulina Pacifica, a highly nutritious dietary supplement
  • Contract extraction services for various industries
Growth Outlook
  • Recent quarterly revenue increased to $7.91 million, showing strong demand
  • Gross profit margin improved to 30.25% in the latest quarter
  • Expansion into new sales channels is anticipated to drive future growth
Financial Highlights
  • Trailing twelve months revenue of $25.5 million reflects steady performance
  • Net income for the latest quarter was -$128,000, indicating ongoing challenges
  • Current ratio of 1.02 suggests adequate short-term financial health
Cyanotech Corporation operates in the packaged foods industry, focusing on health-oriented products that cater to a growing market for dietary supplements. The company's flagship products, BioAstin and Hawaiian Spirulina, are well-regarded for their health benefits, including antioxidant properties and immune support. The recent quarterly performance indicates a positive trend in revenue, with a notable increase to $7.91 million, which reflects the company's ability to attract consumer interest. The gross profit margin has also shown improvement, suggesting effective cost management and pricing strategies. Despite facing challenges, as evidenced by the recent net income loss, the company maintains a current ratio above 1, indicating it can cover its short-term liabilities. The strategic focus on expanding sales channels and enhancing product offerings positions Cyanotech for potential growth in the health and wellness sector. Investors may find interest in the company's commitment to innovation and sustainability, as it continues to leverage its expertise in microalgae cultivation to meet the rising demand for natural health products.
AI Generated • Aug 2, 2026

Industry

Personal Products

Employees

83

CEO

Matthew K. Custer

Headquarters

Kailua-Kona, HI 96740, US

CYAN Financials

Key Financial Metrics (TTM)

Gross Margin

35.41%

Operating Margin

2.28%

Net Income Margin

-0.25%

Return on Equity

-0.87%

Return on Capital

-2.98%

Return on Assets

-0.32%

Earnings Yield

-2.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

7.39M

Volume

19.29K

Avg. Volume

1.55K

Financials (TTM)

Gross Profit

$9.64M

Operating Income

$621.00K

EBITDA

$3.38M

Operating Cash Flow

$146.00K

Capital Expenditure

-$229.00K

Free Cash Flow

-$83.00K

Cash & ST Invst.

$1.09M

Total Debt

$11.37M

Cyanotech Performance Analysis

Cyanotech annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 23,178,000-35.6%
20242024-03-31USD 23,071,000-0.5%
20252025-03-31USD 24,215,0005.0%
20262026-03-31USD 26,587,0009.8%
Cyanotech sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3019.9%
Q32025-12-31-15.8%
Q42026-03-3134.6%
Q12026-06-30-18.3%
Cyanotech annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -0.55N/A
20242024-03-31USD -0.8146.4%
20252025-03-31USD -0.45-43.8%
20262026-03-31USD -0.18-61.3%
Cyanotech sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30100.1%
Q32025-12-31-31200.0%
Q42026-03-3143.1%
Q12026-06-30323.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

$6.47M

+11.1%

Gross Profit

$2.74M

+54.6%

Gross Margin

42.38%

N/A

Market Cap

$3.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$40.08K

N/A

Employees

83

N/A

Net Income

$288.00K

+131.1%

EBITDA

$845.00K

+427.5%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

$1.09M

+185.6%

Total Debt

$11.37M

-4.6%

Accounts Receivable

$2.23M

+42.9%

Inventory

$6.99M

-13.9%

Long Term Debt

$3.60M

-14.6%

Short Term Debt

$7.77M

+0.9%

Return on Assets

-0.32%

N/A

Return on Invested Capital

5.36%

N/A

Free Cash Flow

$364.00K

+136.7%

Operating Cash Flow

$423.00K

+145.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RSAURooshine, Inc.
$0.17-25.72%
PLVFFPlant Veda Foods Ltd.
$0.06+0.00%
CMGHFChaoda Modern Agriculture (Holdings) Limited
$0.01-50.00%
APRUApple Rush Company, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$213.05+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.09+0.01%
INTCIntel
$87.48+0.00%
BITOProShares Trust - ProShares Bitcoin ETF
$10.66+0.00%

Questions About CYAN

What is the current price of Cyanotech?

Cyanotech is trading at $0.45 per share.

What is the 52-week range for Cyanotech?

Over the past 52 weeks, Cyanotech has traded between $0.23 and $0.57.

How much debt does Cyanotech have?

As of the most recent reporting period, Cyanotech reported total debt of $11.37M.

How much cash does Cyanotech have on hand?

Cyanotech reported $1.09M in cash and cash equivalents in its most recent financial results.

What is Cyanotech’s dividend yield?

Cyanotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.